Insights from 2024 WCLC
Playback speed
10 seconds
WCLC 2024 Insights: Highlights of Coming Advances in mNSCLC - Cytotoxics, IO, and KRAS Inhibitors
By
Insights from 2024 WCLC
FEATURING
Brian Henick
By
Insights from 2024 WCLC
FEATURING
Brian Henick
115 views
September 19, 2024
Chapters
Overview & Speaker Introduction
00:00
Dato-DXd vs. Docetaxel: Phase III Results
00:32
TROP2 Biomarker & Dato-DXd Efficacy
03:48
Volrustomig & Chemotherapy in mNSCLC
05:59
KRAS G12C Inhibitors: Divarasib Update
10:18
Key Takeaways & Future Considerations
14:18
Comments 0
Login to view comments.
Click here to Login